Rescuing the last-line polymyxins: achievements and challenges

SC Nang, MAK Azad, T Velkov, QT Zhou, J Li - Pharmacological reviews, 2021 - ASPET
Antibiotic resistance is a major global health challenge and, worryingly, several key Gram
negative pathogens can become resistant to most currently available antibiotics. Polymyxins …

Mechanisms and clinical relevance of bacterial heteroresistance

DI Andersson, H Nicoloff, K Hjort - Nature Reviews Microbiology, 2019 - nature.com
Antibiotic heteroresistance is a phenotype in which a bacterial isolate contains
subpopulations of cells that show a substantial reduction in antibiotic susceptibility …

Managing Acinetobacter baumannii infections

J Garnacho-Montero, JF Timsit - Current opinion in infectious …, 2019 - journals.lww.com
Managing Acinetobacter baumannii infections : Current Opinion in Infectious Diseases
Managing Acinetobacter baumannii infections : Current Opinion in Infectious Diseases Log in or …

Multidrug‐resistant Gram‐negative bacterial infections in solid organ transplant recipients—Guidelines from the American Society of Transplantation Infectious …

SM Pouch, G Patel… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic …

S Karakonstantis, I Saridakis - International journal of antimicrobial agents, 2020 - Elsevier
Background: Colistin is one of the few remaining options for carbapenem-resistant
Acinetobacter baumannii (A. baumannii); however, emergence of resistance from …

[HTML][HTML] Improving therapy of severe infections through drug repurposing of synergistic combinations

YS Cheng, PR Williamson, W Zheng - Current opinion in pharmacology, 2019 - Elsevier
Highlights•Drug combinations improve efficacy and permit dose reductions of each
drug.•Lowering the dose of combined drugs prevents concentration-associated …

Prevalence and clinical consequences of colistin heteroresistance and evolution into full resistance in carbapenem-resistant Acinetobacter baumannii

H Kon, A Hameir, A Nutman, E Temkin… - Microbiology …, 2023 - Am Soc Microbiol
Colistin heteroresistance (HR) refers to a bacterial population comprised of several
subpopulations with different levels of resistance to colistin. In this study, we discuss the …

Pharmacokinetics and pharmacodynamics of peptide antibiotics

X Bian, X Qu, J Zhang, SC Nang, PJ Bergen… - Advanced drug delivery …, 2022 - Elsevier
Antimicrobial resistance is a major global health challenge. As few new efficacious
antibiotics will become available in the near future, peptide antibiotics continue to be major …

Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc …

C Longshaw, A Santerre Henriksen… - Microbiology …, 2023 - Am Soc Microbiol
This study aimed to determine the proportion of heteroresistance in carbapenem-resistant
Acinetobacter calcoaceticus-baumannii complex (CRAB) isolates in the cefiderocol arm of …

Discerning the role of polymicrobial biofilms in the ascent, prevalence, and extent of heteroresistance in clinical practice

SP Lopes, P Jorge, AM Sousa… - Critical Reviews in …, 2021 - Taylor & Francis
Antimicrobial therapy is facing a worrisome and underappreciated challenge, the
phenomenon of heteroresistance (HR). HR has been gradually documented in clinically …